YKYeshwini Murali Krishna

Yeshwini Murali Krishna

*This is an algorithmically generated author record based on publicly available information.

Yeshwini Murali Krishna has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    May–Thurner Syndrome: An Under‐Recognized Etiology of Deep Vein Thrombosis (DVT)

    by Abdul Rehman Shahid Khan, Yashika Gupta, Betsy Samuel, Yeshwini Murali Krishna, Muhammad Husnain Ahmad, Haseeb Ahmad, Iqra Nasir, Masab Ali, Danish Ali Chohan, Muhammad Umar Nadeem, et al.

    Background and Aims: May–Thurner Syndrome (MTS) is a rare vascular condition characterized by the compression of the left iliac vein by the overlying right iliac artery. This anatomical anomaly predisposes patients, especially young to middle‐aged women, to deep vein thrombosis (DVT), which when it persists, leads to complications such as pulmonary embolism and chronic venous insufficiency. Despite its clinical significance, there is a lack of standardized guidelines for diagnosis and management. This review aims to summarize current knowledge on the epidemiology, pathophysiology, diagnostic approaches, and therapeutic strategies for MTS while highlighting challenges in establishing a consistent clinical framework. Methods: A comprehensive literature search was conducted using PubMed and Google Scholar, focusing on English‐language studies involving human subjects. Sources included case reports, case series, clinical trials, systematic reviews, and expert consensus guidelines. Additional literature on iliac vein pathophysiology and venous thromboembolism management was reviewed to provide broader clinical context. Reference lists of key publications were manually examined for additional relevant studies. The final literature search was completed on April 5, 2025. Results: Common diagnostic methods for MTS include duplex ultrasound, CT venography, and MR venography, with intravascular ultrasound showing the highest sensitivity (> 98%). Endovascular stenting, often combined with catheter‐directed thrombolysis, provides significant symptom relief and reduces post‐thrombotic syndrome. In contrast, angioplasty alone was linked to higher recurrence rates. Long‐term patency rates following stenting ranged from 79% to 100%. However, the absence of standardized diagnostic and treatment protocols contributes to variability in clinical outcomes. Conclusion: MTS remains an underrecognized cause of DVT, especially among young women. Although advances in diagnostic imaging and minimally invasive interventions have improved management, the lack of evidence‐based guidelines continues to interfere with optimal care. Early diagnosis and individualized treatment plans are crucial, and further research is needed to establish evidence‐based protocols for consistent management of MTS.

  • Open Access

    Heyde Syndrome: A Literature Review

    by Yashika Gupta, Abdul Rehman Shahid Khan, Viraj Shetty, Yeshwini Murali Krishna, Ayisha Maqsood, Muhammad Husnain Ahmad, Masab Ali, Betsy Samuel, Ali Gohar, Abdul Waheed, et al.

    Background and Aims: Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement. Despite advances, many aspects remain unclear. This review explores the epidemiology, pathophysiology, and management of Heyde syndrome while highlighting areas for future research. Methods: A comprehensive search of PubMed and Google Scholar focused on English‐language human studies, including case reports, clinical trials, reviews, and expert guidelines. Additional literature on Von Willebrand syndrome and GI angiodysplasia was reviewed. The final search was completed on April 5, 2025. Results: Aortic valve replacement improves outcomes and hematologic abnormalities. Transcatheter aortic valve replacement (TAVR) showed lower rates of life‐threatening bleeding, fewer perioperative complications, and reduced transfusions compared to surgical replacement. Guidelines recommend dual antiplatelet therapy (DAPT) for 3–6 months post‐TAVR, with 79%–86% of patients experiencing no recurrence of GI bleeds. Management of intestinal angiodysplasia often shows high recurrence rates due to persistent lesions and vWS‐2A. Surgical valve replacement also improves bleeding control, even with anticoagulation. Aortic valve replacement should be first‐line therapy in severe aortic stenosis with chronic GI bleeding. Conclusion: Heyde syndrome remains a complex and often underrecognized condition in elderly populations. Continued research is critical to deepen understanding and improve patient outcomes, allowing for more personalized and effective care strategies.